Quilatan, Kiesha Alison L.
HRN: 19-34-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
CEFUROXIME 750MG (VIAL)
06/25/2022
07/02/2022
IVTT
375mg
Q8h
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes